This question explores how certain medications function within the body. Many drugs are designed to be administered in a form that isn't immediately active. Instead, they require a transformation process inside the body to become effective.
Drugs that start as inactive substances but are converted into their active form after administration within the body are specifically known as prodrugs. This strategy is often used in drug design to:
The conversion process typically involves biotransformation, a series of metabolic changes, often occurring in the liver, but sometimes in other tissues.
Let's look at why prodrug is the correct term:
Therefore, the term specifically defining an inactive drug that becomes active after being processed by the body is prodrug.
| List-I | List-II |
| Electronic Configuration | First Ionisation energy (kJ mol$^{-1}$) |
| (A). ns$^2$ | (I). 2100 |
| (B). ns$^2$np$^1$ | (II). 1400 |
| (C). ns$^2$np$^3$ | (III). 800 |
| (D). ns$^2$np$^6$ | (IV). 900 |
| List-I | List-II |
| Spectroscopy | Property |
| (A). Raman | (I). Polarizability |
| (B). FTIR | (II). Dipole Moment |
| (C). UV-Visible | (III). Absorbance |
| (D). NMR | (IV). Spin |